Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines - Aix-Marseille Université Access content directly
Journal Articles Frontiers in Immunology Year : 2020

Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines

Abstract

The rapid spread, severity, and lack of specific treatment for COVID-19 resulted in hasty drug repurposing. Conceptually, trials of antivirals were well-accepted, but twentieth century antimalarials sparked an impassioned global debate. Notwithstanding, antiviral and immunomodulatory effects of aminoquinolines have been investigatedin vitro, in vivoand in clinical trials for more than 30 years. We review the mechanisms of action of (hydroxy)chloroquine on immune cells and networks and discuss promises and pitfalls in the fight against SARS-CoV-2, the agent of the COVID-19 outbreak.
Fichier principal
Vignette du fichier
fimmu-11-02159.pdf (2.44 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Licence : CC BY - Attribution

Dates and versions

hal-03149722 , version 1 (26-10-2023)

Licence

Attribution

Identifiers

Cite

Joana Vitte, Moise Michel, Soraya Mezouar, Aissatou Bailo Diallo, Asma Boumaza, et al.. Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines. Frontiers in Immunology, 2020, 11, ⟨10.3389/fimmu.2020.02159⟩. ⟨hal-03149722⟩
21 View
1 Download

Altmetric

Share

Gmail Facebook X LinkedIn More